Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A.

SIX:NWRN.SW

Overview | Financials
Company Name Newron Pharmaceuticals S.p.A.
Symbol NWRN.SW
Currency CHF
Price 7.9
Market Cap 155,849,494
Dividend Yield 0%
52-week-range 4.09 - 11.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Stefan Weber
Website https://www.newron.com

An error occurred while fetching data.

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for

Related Stocks

Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

SANN.SW

9.34 CHF

Kuros Biosciences AG logo

Kuros Biosciences AG

KURN.SW

13 CHF

Evolva Holding SA logo

Evolva Holding SA

EVE.SW

0.91 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

5.93 CHF

Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

RLF.SW

1.16 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD